Leitner, K., Tsibulak, I., Wieser, V., Knoll, K., Reimer, D., Marth, C., . . . Zeimet, A. G. (2020). Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer. Sci Rep.
Chicago Stili AlıntıLeitner, Katharina, Irina Tsibulak, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth, Heidi Fiegl, ve Alain G. Zeimet. "Clinical Impact of EZH2 and Its Antagonist SMARCA4 in Ovarian Cancer." Sci Rep 2020.
MLA AlıntıLeitner, Katharina, et al. "Clinical Impact of EZH2 and Its Antagonist SMARCA4 in Ovarian Cancer." Sci Rep 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..